The Hindu Business Line : Ranbaxy Q4 net dips to Rs 156.5 cr

RANBAXY Laboratories Ltd has recorded consolidated sales of Rs 5,333.3 crore, an 18 per cent growth from last year's Rs 4,530.1 crore for the financial year ended December 31, 2004.

Profit before tax stood at Rs 973.5 crore compared with last year's Rs 1,014.7 crore while net profits stood at Rs 743 crore, down from last year's Rs 759.4 crore.

For the fourth quarter ended December 31, 2004, the consolidated sales of Ranbaxy and its subsidiaries stood at Rs 1,423.5 crore, compared with Rs 1,144.4 crore, a growth of 24 per cent.

Profit before tax during the last quarter stood at Rs 182.6 crore (Rs 246.7 crore) while net profit stood at Rs 156.5 crore (Rs 175.80 crore).

For the year, the company's global sales grew by 21 per cent. While the US accounted for 36 per cent, Europe and BRIC countries constituted 16 per cent and 26 per cent respectively.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Reliance spat: What's in store at ensuing board meetings?

Largest commercial aircraft A380 unveiled

Ranbaxy's Tempest upbeat on 2005

Ranbaxy Q4 net dips to Rs 156.5 cr

Pawar for import of GM oilseeds

Greens shocked by Pawar's remark

Foreign broking firms turn bearish on India

Markets stay jittery over steady FII inflows

Contributions to The Hindu Relief Fund